Crossmark

Alpha-amylase Inhibition by Myricetin Nanoparticles: An In Silico, In Vitro, and In Vivo Evaluation toward Natural Antidiabetic Therapy

Crossref DOI link: https://doi.org/10.1007/s12247-026-10695-8

Published Online: 2026-05-09

Published Print: 2026-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Waghmare, Karishma Ramchandra https://orcid.org/0009-0003-7935-1726
Chakraborthy, Guno Sindhu https://orcid.org/0000-0003-0637-0486
License Information

Text and Data Mining valid from 2026-05-09

Version of Record valid from 2026-05-09
More Information

Article History

Received: 23 January 2026

Accepted: 12 April 2026

First Online: 9 May 2026

Declarations

:

: The authors declare no competing interests.